These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. AIDS and taurolin. Bayardelle P CMAJ; 1986 Mar; 134(5):476. PubMed ID: 3004686 [No Abstract] [Full Text] [Related]
5. [Local chemotherapy of bone infections with Taurolin]. Nentwig GH; Kniha H Zahnarztl Prax; 1984 Oct; 35(10):394-6. PubMed ID: 6594844 [No Abstract] [Full Text] [Related]
6. [Local chemotherapy of osteitis with 4% taurolin-gel]. Lob G; Burri C Fortschr Med; 1983 Jan; 101(3):88-93. PubMed ID: 6826138 [No Abstract] [Full Text] [Related]
7. Clinical studies on administration of taurolin in severe sepsis: a preliminary study. McCartney AC; Browne MK Prog Clin Biol Res; 1988; 272():361-71. PubMed ID: 3293082 [No Abstract] [Full Text] [Related]
8. [Taurolin gel in treatment of osteitis (author's transl)]. Burri C; Lob G Aktuelle Traumatol; 1982 Jun; 12(3):159-65. PubMed ID: 6126089 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of chronic osteomyelitis with Taurolin-Gel (author's transl)]. Götz J; Wesch G Z Orthop Ihre Grenzgeb; 1981 Oct; 119(5):540-3. PubMed ID: 7314830 [TBL] [Abstract][Full Text] [Related]
10. The rate of antimicrobial action of noxythiolin and taurolin. Brearley S; George RH J Hosp Infect; 1980 Sep; 1(3):201-9. PubMed ID: 6182213 [No Abstract] [Full Text] [Related]
11. The treatment of peritonitis by an antiseptic - taurolin. Browne MK Pharmatherapeutica; 1981; 2(8):517-22. PubMed ID: 7255507 [TBL] [Abstract][Full Text] [Related]
12. [Effects and side effects of taurolin in experimental peritonitis in the rat]. Hart H; Seifert J; Brendel W Langenbecks Arch Chir; 1986; 368(3):149-62. PubMed ID: 3807498 [TBL] [Abstract][Full Text] [Related]
13. [Appendicular peritonitis: comparative study of antibiotic therapy and a topical bactericidal agent]. Marti MC; Moser G Helv Chir Acta; 1980 Sep; 47(3-4):463-7. PubMed ID: 7193668 [TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin]. Wesch G; Petermann C; Linder MM Fortschr Med; 1983 Mar; 101(12):545-50. PubMed ID: 6343207 [TBL] [Abstract][Full Text] [Related]
15. Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent. Gorman SP; McCafferty DF; Woolfson AD; Jones DS J Appl Bacteriol; 1987 Apr; 62(4):315-20. PubMed ID: 3298185 [TBL] [Abstract][Full Text] [Related]
16. The relationship between structure and activity of taurolin. Myers E; Allwood MC; Gidley MJ; Sanders JK J Appl Bacteriol; 1980 Feb; 48(1):89-96. PubMed ID: 6989795 [No Abstract] [Full Text] [Related]
17. [Intravenous and intraperitoneal administration of an antiseptic: 65 cases of diffuse peritonitis treated with taurolin]. Marti MC; Moser G; Wicki O; Linder M; del Ponte F Helv Chir Acta; 1980 Feb; 46(5-6):755-8. PubMed ID: 7399955 [No Abstract] [Full Text] [Related]
18. [Treatment of osteomyelitis with resorbable, antiseptic gel]. Götz J; Wicki O Helv Chir Acta; 1983 Jan; 49(5):679-83. PubMed ID: 6833001 [No Abstract] [Full Text] [Related]
19. Prevention of septic complications associated with TPN. Blenkharn JI JPEN J Parenter Enteral Nutr; 1986; 10(4):436-7. PubMed ID: 3091869 [No Abstract] [Full Text] [Related]